학술논문

Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib.
Document Type
Article
Source
JCO Oncology Practice; Sep2023, Vol. 19 Issue 9, p786-792, 9p
Subject
TREATMENT of lung tumors
GENETIC mutation
EPIDERMAL growth factor receptors
INTERVENTIONAL radiology
MOLECULAR pathology
FISHER exact test
PROTEIN-tyrosine kinase inhibitors
HOSPITAL pharmacies
WORKFLOW
T-test (Statistics)
GENE expression profiling
CHI-squared test
DESCRIPTIVE statistics
RESEARCH funding
INTEGRATED health care delivery
POLYMERASE chain reaction
Language
ISSN
26881527
Abstract
Copyright of JCO Oncology Practice is the property of American Society of Clinical Oncology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)